Listed

Stepan Co: Form 10-Q for the period ended Jun 30, 2015

Filed with the SEC on Jul 29, 2015 and accepted by EDGAR at Jul 29, 2015, 11:18 ET.

Share

Management's discussion and analysis

As filed, 63,976 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.

The matters discussed in the following discussion and analysis include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.

Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

  • Surfactants – Surfactants, which accounted for 69 percent of consolidated net sales in the first half of 2015, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery or EOR). The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results. Sales and related profits of the Company’s surfactants to enhanced oil recovery customers are included in surfactants segment results.
  • Polymers – Polymers, which accounted for 27 percent of consolidated net sales in the first half of 2015, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively CASE products) and flexible foams. Polyester resins, which include liquid and powdered products, are used in CASE and polyurethane systems house applications. CASE, polyester resins and flexible foam are collectively referred to as specialty polyols. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the U.S., polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and specialty polyols are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyols are manufactured at the Company’s subsidiary in Germany and specialty polyols are manufactured at the Company’s Poland subsidiary. In Asia, polyols are currently toll produced for the Company’s 80-percent owned joint venture in Nanjing, China. The Company is building a new plant in Nanjing that is expected to be operational in the first half of 2016.
  • Specialty Products – Specialty products, which accounted for 4 percent of consolidated net sales in the first half of 2015, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

Business Acquisition

On June 15, 2015, the Company closed on the previously announced agreement with Procter & Gamble do Brasil S.A. (P&G Brazil) to acquire P&G Brazil’s sulfonation production facility in Bahia, Brazil. The facility is located in northeastern Brazil and has 30,000 metric tons of surfactants capacity. The acquisition will be included in Latin American operations of the Company’s Surfactants segment. The acquired business complements the Company’s existing Vespasiano, Brazil, plant and provides opportunities to serve growing northeastern Brazil. See Note 16 to the notes to condensed consolidated financial statements for further information.

Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

(In millions)

Income (Expense) For the Three Months Ended June 30 2015 2014 Change
Deferred Compensation (Administrative expense) $(6.6) $5.5 $(12.1) (1)
Realized/Unrealized Gains on Investments (Other, net) 0.1 0.5 (0.4)
Investment Income (Other, net) — — —
Pretax Income Effect $(6.5) $6.0 $(12.5)

(In millions)

Income (Expense) For the Six Months Ended June 30 2015 2014 Change
Deferred Compensation (Administrative expense) $(8.2) $5.7 $(13.9) (1)
Realized/Unrealized Gains on Investments (Other, net) 0.6 0.5 0.1
Investment Income (Other, net) 0.1 0.2 (0.1)
Pretax Income Effect $(7.5) $6.4 $(13.9)

(1) See the Corporate Expenses section of this management’s discussion and analysis for details regarding the quarter-over-quarter change in deferred compensation expense.

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three and six months ended June 30, 2015 and 2014:

(In millions)

Three Months Ended June 30 2015 2014 Increase (Decrease) (Decrease) Due to Foreign Currency Translation
Net Sales $452.4 $504.1 $(51.7) $(33.6)
Gross Profit 79.5 71.6 7.9 (5.1)
Operating Income 28.6 36.9 (8.3) (3.1)
Pretax Income 24.1 33.2 (9.1) (2.6)

(In millions)

Six Months Ended June 30 2015 2014 Increase (Decrease) (Decrease) Due to Foreign Currency Translation
Net Sales $912.9 $$981.6 $(68.7) $(63.2)
Gross Profit 156.0 134.6 21.4 (10.0)
Operating Income 63.8 59.4 4.4 (6.1)
Pretax Income 54.7 51.3 3.4 (5.1)

21

RESULTS OF OPERATIONS

Three Months Ended June 30, 2015 and 2014

Summary

Net income attributable to the Company for the second quarter of 2015 declined 31 percent quarter over quarter to $16.9 million, or $0.74 per diluted share, from $24.4 million, or $1.06 per diluted share, for the second quarter of 2014. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the second quarter of 2015 follows the summary.

Consolidated net sales declined $51.7 million, or 10 percent, between quarters. The decrease resulted from the unfavorable effects of foreign currency translation and from lower selling prices, which had negative effects of $33.6 million and $24.9 million, respectively, on the quarter-over-quarter net sales change. The unfavorable foreign currency translation effect reflected a stronger U.S. dollar against all currencies for countries where the Company has foreign operations. The decreased selling prices were primarily attributable to lower raw material costs. Sales volume increased one percent, which had a $6.8 million favorable impact on the change in net sales. The Surfactants and Polymers segments accounted for the consolidated sales volume improvement, growing one percent and three percent, respectively. Sales volumes for the Specialty Products segment declined seven percent.

Operating income for the second quarter of 2015 declined $8.3 million, or 23 percent, from operating income reported for the same period of last year. Increased deferred compensation expense and the effects of foreign currency translation negatively affected the quarter-over-quarter operating income change by $12.1 million and $3.1 million, respectively. Gross profit increased $7.9 million, or 11 percent, largely due to improved results for Surfactants and Polymers.

Operating expenses increased $16.2 million, or 47 percent, between quarters. The effects of foreign currency translation reduced the quarter-over-quarter operating expense increase by $2.1 million. The following summarizes the changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Administrative expenses increased $15.0 million, or 166 percent, quarter over quarter due to increases for deferred compensation ($12.1 million), fringe benefit ($1.0 million), consulting ($0.9 million) and talent acquisition ($0.7 million) expenses. A second quarter 2015 increase in the value of Company common stock compared to a second quarter 2014 decrease in the value of Company common stock led to the increase in deferred compensation expense (see the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details). Higher incentive-based compensation (i.e., bonus, profit sharing and stock-based compensation) and group insurance costs accounted for the increase in fringe benefit expenses. The increase in consulting expenses was primarily related to outside advisory fees for services supporting the Company’s ongoing initiative (referred to as ‘DRIVE’ within the Company) to improve efficiency across the Company’s global organization. The effects of foreign currency translation reduced the quarter-over-quarter operating expense increase by $1.0 million.
  • Selling expenses increased $0.8 million, or six percent, quarter over quarter largely due to higher fringe benefit ($1.0 million) and bad debt ($0.4 million) expenses. Higher incentive-based compensation and group insurance costs accounted for the increase in fringe benefit expenses. The increase in bad debt expense reflected an increase in the allowance for uncollectible accounts for a high-risk customer. The effects of foreign currency translation reduced the quarter-over-quarter operating expense increase by $0.7 million.
  • Research, development and technical service (R&D) expenses increased $0.5 million, or four percent, quarter over quarter largely due to higher incentive-based compensation and group insurance expenses. The effects of foreign currency translation reduced the quarter-over-quarter operating expense increase by $0.4 million.

The loss from the Company’s 50-percent equity joint venture (TIORCO) increased $0.6 million quarter over quarter principally due to higher expenses associated with restructuring charges and to lower technical service income.

Other, net was $0.2 million of income for the second quarter of 2015 compared to $0.6 million of income for the same period of 2014. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was $0.1 million in the second quarter of 2015 compared to $0.6 million in last year’s second quarter. Additionally, the Company reported foreign exchange gains of $0.1 million in the second quarter of 2015 compared to less than $0.1 million of loss in the second quarter of 2014.

The effective tax rate was 29.8 percent for the second quarter of 2015 compared to 26.6 percent for the second quarter of 2014. The increase was primarily attributable to an unfavorable non-recurring tax charge related to a foreign income tax audit recorded in the second quarter of 2015 and a favorable non-recurring tax benefit related to a foreign transfer pricing adjustment recorded in the second quarter of 2014. The effective tax rates for the second quarter of 2015 and 2014 do not include the impact of the U.S. federal research and development credit. The credit has not yet been re-enacted in 2015, and in 2014 the research and development credit was enacted in the fourth quarter.

Segment Results

(In thousands)

Net Sales For the Three Months Ended June 30, 2015 June 30, 2014 (Decrease) Percent Change
Surfactants $299,743 $333,761 $(34,018) -10
Polymers 133,613 148,270 (14,657) -10
Specialty Products 19,058 22,080 (3,022) -14
Total Net Sales $452,414 $504,111 $(51,697) -10

(In thousands)

Operating Income For the Three Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
Surfactants $24,232 $19,239 $4,993 +26
Polymers 23,429 18,444 4,985 +27
Specialty Products 1,522 3,550 (2,028) -57
Segment Operating Income $49,183 $41,233 $7,950 +19
Corporate Expenses, Excluding Deferred Compensation $14,015 $9,736 $4,279 +44
Deferred Compensation Expense (Income) 6,573 (5,417) 11,990 NM
Total Corporate Expenses $20,588 $4,319 $16,269 +377
Total Operating Income $28,595 $36,914 $(8,319) -23

Surfactants

Surfactants net sales for the second quarter of 2015 declined $34.0 million, or 10 percent, from net sales for the second quarter of 2014. Sales volume increased one percent between years, which had a $3.1 million positive effect on the quarter-over-quarter net sales change. Foreign currency translation and lower selling prices had a $24.0 million and $13.1 million negative effect, respectively, on the net sales change. Compared to the year-ago quarter, the U.S. dollar was stronger against all currencies of the segment’s foreign operations. Lower costs for major raw materials led to the decreases in selling prices. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended June 30, 2015 June 30, 2014 (Decrease) Percent Change
North America $184,748 $203,003 $(18,255) -9
Europe 63,269 72,754 (9,485) -13
Latin America 36,702 42,587 (5,885) -14
Asia 15,024 15,417 (393) -3
Total Surfactants Segment $299,743 $333,761 $(34,018) -10

Net sales for North American operations declined nine percent due to decreased selling prices, a two percent decrease in sales volume and the unfavorable effects of foreign currency translation, which accounted for $11.9 million, $4.6 million and $1.8 million, respectively, of the net sales decline. The average unit selling price declined six percent quarter over quarter, reflecting decreased raw material costs. Decreased sales volumes of products used in oil field, biodiesel and household, industrial and institutional (HI&I) applications accounted for most of the sales decline. These decreases were partially offset by increased sales volumes of products used in agricultural chemical, laundry and cleaning and personal care applications. The foreign currency effect reflected a stronger U.S. dollar relative to the Canadian dollar.

Net sales for European operations declined 13 percent quarter over quarter. Sales volume was up nine percent, resulting in a $6.7 million quarter-over-quarter increase in net sales. The sales volume impact was more than offset by the unfavorable effects of foreign currency translation ($11.9 million). In addition, selling prices declined five percent, which negatively affected the quarter-over-quarter change in net sales by $4.3 million. An increase in sales of laundry and cleaning and agricultural chemical products, due to stronger quarter-over-quarter demand from existing customers and new business, led to the improvement in sales volume. A stronger U.S. dollar against the European euro and British pound sterling led to the foreign currency translation result. The reduced selling prices primarily resulted from lower raw material costs for some major raw materials.

Net sales for Latin American operations declined 14 percent due to a $10.2 million unfavorable effect of foreign currency translation. A five percent increase in sales volume and higher selling prices offset the foreign currency translation impact by $2.3 million and $2.0 million, respectively. Higher sales volume for Brazil operations accounted for the increased Latin American sales volume. The foreign currency translation effect resulted from the quarter-over-quarter weakening of the Brazilian real and Colombian and Mexican pesos against the U.S. dollar.

Net sales for Asian operations declined three percent primarily due to a seven percent decrease in sales volume.

Surfactants operating income for the second quarter of 2015 increased $5.0 million, or 26 percent, over operating income for the second quarter of 2014. Gross profit increased $5.3 million, primarily on improved results for North American operations. The effects of foreign currency translation reduced Surfactants quarter-over-quarter gross profit increase by $3.8 million. Operating expenses increased $0.3 million, or one percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
North America $29,964 $23,357 $6,607 +28
Europe 6,646 7,024 (378) -5
Latin America 5,742 4,739 1,003 +21
Asia 3,771 5,726 (1,955) -34
Surfactants Segment Gross Profit $46,123 $40,846 $5,277 +13
Operating Expenses 21,891 21,607 284 +1
Operating Income $24,232 $19,239 $4,993 +26

North American gross profit increased 28 percent between quarters due to improved sales margins that more than offset the effect of the two percent decrease in sales volume. The favorable resolution of a previously recorded customer claim also contributed to the higher gross profit. The improved sales margin reflected an improved sales mix and lower raw material and transportation costs. Last year’s second quarter included additional transportation costs due to production issues at the Anaheim, California, plant that resulted in shifting production to other Company locations. Second quarter 2014 gross profit also included $0.9 million of accelerated depreciation related to the Company’s Canadian plant restructuring that was approved in the fourth quarter of 2013.

Gross profit for European operations declined five percent quarter over quarter primarily due to a $1.5 million unfavorable impact of foreign currency translation that more than offset the effects of the nine percent sales volume increase and sales margin improvements.

Gross profit for Latin American operations increased 21 percent despite a $1.9 million unfavorable effect of foreign currency translation. The gross profit improvement resulted from a more profitable mix of sales, higher selling prices and the five percent increase in sales volume.

Asia gross profit declined 34 percent largely due to the seven percent decrease in sales volume and a less favorable mix of sales.

Operating expenses for the Surfactants segment increased $0.3 million, or one percent, between quarters. The increase between years included higher incentive-based compensation and group insurance expenses offset by the effects of foreign currency translation.

Polymers

Polymers net sales for the second quarter of 2015 declined $14.7 million, or 10 percent, from net sales for the second quarter of 2014. Sales volume was up three percent between quarters, which had a $4.4 million favorable effect on the net sales change between quarters. Lower selling prices and the effects of foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $10.4 million and $8.7 million, respectively. Quarter-over-quarter raw material cost declines led to the decrease in selling prices. The foreign currency translation effect reflected a stronger U.S. dollar against the currencies of the segment’s foreign operations. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended June 30, 2015 June 30, 2014 (Decrease) Percent Change
North America $87,564 $94,022 $(6,458) -7
Europe 38,929 46,105 (7,176) -16
Asia and Other 7,120 8,143 (1,023) -13
Total Polymers Segment $133,613 $148,270 $(14,657) -10

Net sales for North American operations declined seven percent. Sales volume was up less than one percent between quarters as rigid polyol volume improvement (up five percent) was largely offset by volume declines for specialty polyols (down 11 percent). Lower selling prices, driven by lower raw material costs, had a $6.9 million unfavorable impact on the quarter-over-quarter net sales change.

Net sales for European operations declined 16 percent despite an eight percent improvement in sales volume. The effect of the increased sales volume was more than offset by an $8.5 million unfavorable impact of foreign currency translation, resulting from a stronger U.S. dollar relative to the European euro. The sales volume gain reflected seven percent and nine percent increases, respectively, for rigid polyol and specialty polyol products.

Net sales for Asia and Other operations declined 13 percent quarter over quarter due to a decline in selling prices precipitated by lower raw material costs. Sales volume increased five percent due to higher sales volume to customers in China and other Asian countries. The Company continues to supply customers in China and other parts of Asia with product imported from other Company plants and local manufacturers. This outsourcing is expected to continue until construction of the new plant in China is complete, which is currently projected to be in the first half of 2016.

Polymer operating income for the second quarter of 2015 increased $5.0 million, or 27 percent, over operating income for the second quarter of 2014. Gross profit increased $6.3 million quarter-over-quarter due to a lower raw material inventory cost position and the three percent increase in sales volume partially offset by a $1.3 million unfavorable effect of foreign currency translation. Operating expenses increased $1.3 million, or 19 percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
North America $25,437 $17,773 $7,664 +43
Europe 5,367 6,794 (1,427) -21
Asia and Other 643 589 54 +9
Polymers Segment Gross Profit $31,447 $25,156 $6,291 +25
Operating Expenses 8,018 6,712 1,306 +19
Operating Income $23,429 $18,444 $4,985 +27

Gross profit for North American operations increased 43 percent quarter over quarter primarily due to a lower raw material inventory cost position. In addition, 2015 gross profit included the recognition of $1.0 million of previously deferred revenue due to the satisfaction of contractual requirements.

Gross profit for European operations declined 21 percent primarily due to a $1.2 million unfavorable impact of foreign currency translation. The effect of higher sales volume was offset by higher manufacturing costs.

The increase in gross profit for Asia and Other operations was due to the five percent increase in sale volume.

Operating expenses for the polymers segment increased $1.3 million, or 19 percent, quarter over quarter. Higher incentive-based pay, group insurance and bad debt reserve expenses accounted for most of the operating expense increase. The bad debt reserve increase reflected an increase in the allowance for uncollectible accounts for a high-risk customer. In addition, operating expenses in China, where a new plant is being constructed, increased $0.5 million quarter over quarter. Foreign exchange translation reduced the quarter-over-quarter operating expense increase by $0.4 million.

Specialty Products

Net sales for the second quarter of 2015 declined $3.0 million, or 14 percent, from net sales for the second quarter of 2014. A seven percent decrease in sales volume, the unfavorable effects of foreign currency translation and lower selling prices accounted for $1.5 million, $0.8 million and $0.7 million, respectively, of the quarter-over-quarter net sales decrease. All product lines contributed to the sales volume decline. Selling prices were lower largely due to competitive pressures for nutritional supplement products. Operating income decreased $2.0 million, or 57 percent, quarter over quarter due to lower sales volume and selling prices, higher raw material costs and an unfavorable mix of sales due to the timing of pharmaceutical orders.

Corporate Expenses

Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, increased $16.3 million to $20.6 million for the second quarter of 2015 from $4.3 million for the second quarter of 2014. Large contributors to the quarter-over-quarter increase in corporate expenses included higher deferred compensation ($12.0 million), fringe benefit ($1.6 million), consulting ($0.9 million) and talent acquisition ($0.7 million) expenses. Deferred compensation was $6.6 million of expense for the second quarter of 2015 compared to $5.5 million of income for the second quarter of 2014. The change between quarters was primarily attributable to a $12.45 per share increase in the value of Company common stock in the second quarter of 2015 compared to an $11.70 per share decrease for the same quarter of last year. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expense:

2015 6/30 3/31 2014 6/30 3/31
Company Stock Price $54.11 $41.66 $52.86 $64.56

Fringe benefit expenses were higher between quarters principally due to increased incentive-based compensation (both short- and long-term) and group insurance expenses. The increase in consulting expenses was primarily related to the Company’s ongoing DRIVE initiative to improve efficiency across the Company’s global organization.

Six Months Ended June 30, 2015 and 2014

Summary

Net income attributable to the Company for the first half of 2015 increased two percent year over year to $38.2 million, or $1.67 per diluted share, from $37.4 million, or $1.63 per diluted share, for the first half of 2014. Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first half of 2015 follows the summary.

Consolidated net sales declined $68.7 million, or seven percent, between years. The decrease was attributable to the unfavorable effects of foreign currency translation and lower selling prices, which accounted for $63.2 million and $23.7 million, respectively, of the year-over-year net sales change. The unfavorable foreign currency translation effect reflected a stronger U.S. dollar against all currencies of countries where the Company has foreign operations. A two percent increase in sales volume favorably affected the net sales change by $18.2 million. The Surfactants and Polymers segments accounted for the consolidated sales volume improvement, growing one percent and four percent, respectively. Sales volumes for the specialty products segment declined five percent.

Operating income for the first half of 2015 increased $4.3 million, or seven percent, over operating income reported for the same period of 2014. Increased deferred compensation expense and the effects of foreign currency translation negatively affected the year-over-year operating income change by $13.9 million and $6.1 million, respectively. Included in the 2015 results was a $2.9 million gain on the divestiture of the Company’s specialty polyurethane systems product line (part of the Polymers segment). See Note 14 to the condensed consolidated financial statements for additional information regarding the sale. Gross profit increased $21.3 million, or 16 percent, due to improved results for Surfactants and Polymers.

Operating expenses increased $19.9 million, or 26 percent, between years. The favorable effects of foreign currency translation reduced the year-over-year operating expense increase by $3.9 million. The following summarizes the changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Administrative expenses increased $19.9 million, or 85 percent, year over year due to increases for deferred compensation ($13.9 million), consulting ($2.3 million), fringe benefits ($1.5 million), talent acquisition ($0.7 million) and environmental remediation ($0.6 million) expenses. In addition, expenses are up $0.7 million in China, where a new plant is being constructed. A 2015 first half increase in the value of Company common stock compared to a 2014 first half decrease led to the increase in deferred compensation expense (see the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details). The increase in consulting expenses was related to the Company’s ongoing DRIVE initiative. Higher incentive-based compensation and group insurance costs accounted for the increase in fringe benefit expenses. A 2015 first quarter increase in the remediation liability for the Company’s Maywood, New Jersey, site led to the increase in environmental remediation expense. The effects of foreign currency translation reduced the year-over-year operating expense increase by $1.7 million.
  • Selling expenses declined $0.4 million, or one percent, year over year due to a $1.6 million favorable foreign currency translation effect. A $1.4 million increase in fringe benefits, notably incentive-based compensation and group insurance, partially offset the translation impact.
  • R&D expenses increased $0.3 million, or one percent, year over year primarily due to higher fringe benefit expenses ($1.6 million) partially offset by the favorable effects of foreign currency translation ($0.6 million) and reduced salary expense ($0.5 million) attributable to the voluntary retirement program associated with the Company’s 2014 restructuring.

The loss from the Company’s 50-percent equity joint venture (TIORCO) increased $0.4 million year over year principally due to restructuring charges.

Other, net was $0.9 million of income for the first half of 2015 compared to $0.5 million of income for the first half of 2014. The Company reported foreign exchange gains of $0.1 million in the first half of 2015 versus $0.3 million of losses for the same period of last year. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was essentially unchanged between years.

The effective tax rate was 30.1 percent for the first half of 2015 compared to 27.1 percent for the first half of 2014. The increase was attributable to an unfavorable non-recurring tax charge related to a foreign income tax audit recorded in the second quarter of 2015 and a favorable non-recurring tax benefit related to a foreign transfer pricing adjustment recorded in the second quarter of 2014. The increase was also attributable to changes in the geographical mix of income. The effective tax rates for the first half of 2015 and 2014 do not include the impact of the U.S. federal research and development credit. The credit has not yet been re-enacted in 2015, and in 2014 the research and development credit was enacted in the fourth quarter.

Segment Results

(In thousands)

Net Sales For the Six Months Ended June 30, 2015 June 30, 2014 (Decrease) Percent Change
Surfactants $630,294 $669,471 $(39,177) -6
Polymers 242,977 267,377 (24,400) -9
Specialty Products 39,594 44,705 (5,111) -11
Total Net Sales $912,865 $981,553 $(68,688) -7

(In thousands)

Operating Income For the Six Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
Surfactants $57,996 $37,577 $20,419 +54
Polymers 38,214 29,270 8,944 +31
Specialty Products 3,766 7,571 (3,805) -50
Segment Operating Income $99,976 $74,418 $25,558 +34
Corporate Expenses, Excluding Deferred Compensation $28,053 $20,646 $7,407 +36
Deferred Compensation Expense (Income) 8,150 (5,665) 13,815 NM
Total Corporate Expenses $36,203 $14,981 $21,222 +142
Total Operating Income $63,773 $59,437 $4,336 +7

Surfactants

Surfactants net sales for the first half of 2015 declined $39.2 million, or six percent, from net sales for the first half of 2014. Sales volume increased one percent between years, which had a $9.2 million positive effect on the year-over-year net sales change. Foreign currency translation and decreased selling prices had negative effects of $45.2 million and $3.2 million, respectively, on the net sales change. Compared to last year’s first half, the U.S. dollar was stronger against all currencies of the segment’s foreign operations. A year-over-year comparison of net sales by region follows:

(In thousands)

For the Six Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
North America $389,551 $411,427 $(21,876) -5
Europe 135,412 148,112 (12,700) -9
Latin America 74,516 81,294 (6,778) -8
Asia 30,815 28,638 2,177 +8
Total Surfactants Segment $630,294 $669,471 $(39,177) -6

Net sales for North American operations declined five percent due to a three percent decrease in sales volume, a two percent decline in selling prices and the unfavorable effects of foreign currency translation, which accounted for $11.8 million, $6.7 million and $3.4 million, respectively, of the year-over-year net sales decline. Decreased sales volumes of products used in oil field, HI&I, agricultural chemical, and laundry and cleaning applications accounted for most of the sales decline. These decreases were partially offset by increased sales volumes of products used in personal care applications. The decline in oil field sales volume reflected lower sales to EOR customers due to decreases in crude oil prices. HI&I sales volume was down mainly due to some lost business, while sales volume of agricultural chemicals declined due to customers’ carryover inventory from last year and to farmers’ efforts to reduce spraying costs due to lower crop prices. The decline in laundry and cleaning sales volume was principally attributable to customers bringing surfactant production in-house beginning in the second quarter of 2014 to more fully utilize their internal capacity. Personal care sales volumes increased due principally due to higher demand from an existing customer. The decline in selling prices reflected decreased raw material costs. The foreign currency effect reflected a stronger U.S. dollar relative to the Canadian dollar.

Net sales for European operations declined nine percent between years. Sales volume was up 10 percent, resulting in a $14.9 million year-over-year increase in net sales. The sales volume impact was more than offset by a $24.8 million unfavorable effect of foreign currency translation. In addition, selling prices declined two percent, which negatively affected the year-over-year net sales change by $2.8 million. An increase in sales of laundry and cleaning and agricultural chemical products, due to stronger demand from existing customers and new business, led to the improvement in sales volume. A stronger U.S. dollar against the European euro and British pound sterling led to the foreign currency translation result.

Net sales for Latin American operations declined eight percent due to a $16.9 million unfavorable effect of foreign currency translation. Higher selling prices and a five percent increase in sales volume offset the foreign currency translation impact by $6.0 million and $4.1 million, respectively. Higher sales volume for Brazil operations accounted for most of the increased Latin American sales volume. The foreign currency translation effect resulted from the year-over-year weakening of the Brazilian real and Colombian and Mexican pesos against the U.S. dollar.

Net sales for Asian operations increased eight percent due to increased selling prices and a three percent increase in sales volume, which accounted for $1.4 million and $0.8 million, respectively, of the year-over-year increase in net sales.

Surfactants operating income for the first half of 2015 increased $20.4 million, or 54 percent, over operating income for the first half of 2014. Gross profit increased $19.7 million, largely due to improved results for North American operations. Foreign currency translation reduced the year-over-year gross profit increase by $7.4 million. Operating expenses declined $0.7 million, or two percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Six Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
North America $64,768 $48,330 $16,438 +34
Europe 16,178 14,360 1,818 +13
Latin America 12,915 10,042 2,873 +29
Asia 7,491 8,922 (1,431) -16
Surfactants Segment Gross Profit $101,352 $81,654 $19,698 +24
Operating Expenses 43,356 44,077 (721) -2
Operating Income $57,996 $37,577 $20,419 +54

North American gross profit increased 34 percent year over year due to higher sales margins that more than offset the effect of decreased sales volume. The favorable 2015 second quarter resolution of a previously recorded customer claim also contributed to the higher gross profit. The improved sales margin resulted from a more favorable sales mix as well as lower raw material and transportation costs. In the first half of 2014, the Company incurred additional transportation expenses due to carrier delays and suboptimal supply chain movements related to the effects of severe winter weather and to production issues at the Anaheim, California, plant that resulted in shifting production to other Company locations. In addition to the foregoing, 2014 first-half gross profit also included $1.8 million of accelerated depreciation related to the Company’s restructuring plan that was approved in the fourth quarter of 2013.

Gross profit for European operations increased 13 percent between years principally due to the 10 percent increase in sales volume and sales margin improvement that resulted from a more favorable mix of sales and from raw material cost declines that outpaced selling price decreases. Foreign currency translation had a $3.3 million unfavorable effect on the year-over-year change in gross profit.

Gross profit for Latin American operations increased 29 percent largely due to a more profitable mix of sales, higher selling prices and the five percent increase in sales volume that more than offset an unfavorable foreign currency translation impact of $3.3 million.

Asia gross profit declined 16 percent largely due to a less profitable mix of sales.

Operating expenses for the surfactants segment declined $0.7 million, or two percent, year over year primarily due to the effects of foreign currency translation. Higher incentive-based compensation and group insurance expenses were partially offset by the effects of foreign currency translation.

Polymers

Polymers net sales for the first half of 2015 declined $24.4 million, or nine percent, from net sales for the first half of 2014. Sales volume was up four percent between years, which had a $10.3 million favorable effect on the net sales change between years. Lower selling prices and the effects of foreign currency translation negatively impacted the year-over-year net sales change by $18.2 million and $16.5 million, respectively. Decreases in raw material costs led to the decline in selling prices. The foreign currency translation effect reflected a stronger U.S. dollar against the currencies of the segment’s foreign operations. A year-over-year comparison of net sales by region follows:

(In thousands)

For the Six Months Ended June 30, 2015 June 30, 2014 (Decrease) Percent Change
North America $158,482 $167,707 $(9,225) -6
Europe 73,256 87,781 (14,525) -17
Asia and Other 11,239 11,889 (650) -5
Total Polymers Segment $242,977 $267,377 $(24,400) -9

Net sales for North American operations declined six percent. Sales volume increased three percent, which had a $4.3 million favorable effect on the year-over-year net sales change. Sales volume of rigid polyols and phthalic anhydride increased three percent and 17 percent, respectively, while sales volume for specialty polyols declined seven percent. Lower selling prices had a $13.5 million unfavorable impact on the net sales change. Decreases in the cost of major raw materials led to the reduction in sales prices.

Net sales for European operations declined 17 percent year-over-year. Sales volume increased five percent, which positively affected the year-over-year net sales change by $4.1 million. Sales volume for rigid polyols increased six percent, while sales volume for specialty polyols fell 5 percent. The unfavorable effects of foreign currency translation resulted in $16.0 million of reduced year-over-year net sales. The foreign currency translation effect reflected a stronger U.S. dollar relative to the European euro. In addition to the foreign currency impact, selling prices declined three percent principally due to a decline in rigid polyol raw material costs.

Net sales for Asia and Other operations declined five percent despite a 15 percent increase in sales volume. The growth in sales volume led to a $1.8 million improvement in year-over-year net sales. The volume gain reflected increased sales volume in Asia and Brazil. Lower selling prices, resulting from raw material cost declines, and the unfavorable effects of foreign currency translation reduced the year-over-year change in net sales by $1.9 million and $0.5 million, respectively.

Polymer operating income for the first half of 2015 increased $8.9 million, or 31 percent, over operating income for the first half of 2014. The 2015 results included the previously discussed $2.9 million gain on the sale of the Company’s specialty polyurethane systems product line. Gross profit increased $7.2 million between years due to the four percent increase in sales volume and lower raw material inventory cost position, partially offset by a $2.4 million unfavorable effect of foreign currency translation. Operating expenses (excluding the gain on the product line sale) increased $1.1 million, or eight percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Six Months Ended June 30, 2015 June 30, 2014 Increase (Decrease) Percent Change
North America $38,174 $29,207 $8,967 +31
Europe 10,366 12,315 (1,949) -16
Asia and Other 1,062 899 163 +18
Polymers Segment Gross Profit $49,602 $42,421 $7,181 +17
Operating Expenses (incl. gain on sale of product line) 11,388 13,151 (1,763) -13
Operating Income $38,214 $29,270 $8,944 +31

Gross profit for North American operations increased 31 percent year over year due to the sales volume improvement and to lower raw material inventory cost position. In addition, 2015 gross profit included the recognition of $1.0 million of previously deferred revenue due to the satisfaction of contractual requirements.

Gross profit for European operations declined 16 percent primarily due to a $2.3 million unfavorable impact of foreign currency translation. The impact of the five percent increase in sales volume partially mitigated the effect of foreign currency translation.

The increase in gross profit for Asia and Other operations was due to increased sale volume that more than offset the effects of foreign currency translation.

Operating expenses for the polymers segment (excluding the $2.9 million gain on the product line sale) increased $1.1 million, or eight percent, year over year. Higher incentive-based pay, group insurance and bad debt reserve expenses accounted for most of the operating expense increase. The bad debt reserve expense increase reflected an increase in the allowance for uncollectible accounts for a high-risk customer. In addition, operating expenses in China, where a new plant is being constructed, increased $0.7 million year over year. Foreign exchange translation reduced the year-over-year operating expense increase by $0.8 million.

Specialty Products

Net sales for the first half of 2015 declined $5.1 million, or 11 percent, from net sales for the same period of 2014. A five percent decrease in sales volume, the unfavorable effects of foreign currency translation and lower selling prices accounted for $2.1 million, $1.6 million and $1.4 million, respectively, of the year-over-year net sales decrease. Lower sales of products used in food and nutritional supplement applications accounted for the sales volume decline. Selling prices were lower largely due to competitive pressures for nutritional supplement products. Operating income decreased $3.8 million, or 50 percent, between years due to lower sales volume and selling prices, higher raw material costs and an unfavorable mix of sales due to the timing of pharmaceutical orders.

Corporate Expenses

Corporate expenses increased $21.2 million to $36.2 million for the first half of 2015 from $15.0 million for the first half of 2014. The significant contributors to the year-over-year increase in corporate expenses included higher deferred compensation ($13.8 million), consulting ($2.3 million), fringe benefit ($2.2 million), talent acquisition ($0.7 million) and environmental remediation ($0.6 million) expenses. Deferred compensation was $8.2 million of expense for the first half of 2015 compared to $5.7 million of income for the first half of 2014. The change between years was largely attributable to a $14.03 per share increase in the value of Company common stock in the first half of 2015 compared to a $12.77 per share decrease for the same period of last year. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expense:

2015 6/30 2014 12/31 6/30 2013 12/31
Company Stock Price $54.11 $40.08 $52.86 $65.63

Consulting expenses increased largely due to the Company’s ongoing DRIVE initiative to improve efficiency across the Company’s global organization. The increase in fringe benefit expenses resulted primarily from higher incentive-based compensation (both short- and long-term) and group insurance expenses. An increase in the remediation liability for the Company’s Maywood, New Jersey, site accounted for the increase in environmental remediation expense.

LIQUIDITY AND CAPITAL RESOURCES

For the six months ended June 30, 2015, operating activities were a cash source of $78.3 million versus a source of $15.0 million for the comparable period in 2014. For the current year period, investing cash outflows totaled $57.6 million and financing activities were a use of $19.7 million. Cash decreased by $2.9 million with exchange rates reducing cash by $3.8 million.

For the current year-to-date, net income was up by $0.9 million and working capital was a source of less than $0.1 million versus a use of $51.9 for the comparable year-ago period. Cash outflows for investing activities were up by $15.2 million year over year. Cash flow for financing activities was a use of $19.7 million in 2015 compared to a use of $9.9 million in 2014.

For the current year-to-date, accounts receivable were a use of $0.7 million compared to a use of $39.1 million for the comparable period in 2014. Inventories were a use of $0.2 million in 2015 versus a use of $30.6 million in 2014. Accounts payable and accrued liabilities were a source of $3.4 million in 2015 compared to a source of $16.5 million for the same period in 2014.

Working capital requirements were lower during the first half of 2015 compared to the same period in 2014 primarily due to lower raw material prices, partially offset by higher inventory and sales quantities. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.

The accounts receivable increase for the first six months was driven mainly by higher sales quantities, mostly offset by lower sales prices. The inventory cash use for the first half was driven mainly by higher inventory quantities, almost entirely offset by lower raw material prices. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2015.

Investing cash outflows for the first six months of 2015 included capital expenditures of $54.0 million compared to $39.1 million for the comparable period last year. Other investing activities were a use of $3.6 million in 2015 versus a use of $3.4 million in 2014. Other investing activities in 2015 included $5.1 million used to purchase the production facility in Bahia, Brazil and $3.3 million from proceeds on the sale of the specialty polyurethane systems product line.

For 2015, the Company estimates that capital expenditures will range from $120 million to $140 million including capacity expansions in the United States, China, and Brazil.

The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. The Company made no open market share repurchases during the first half of 2015. At June 30, 2015, there were 803,679 shares remaining under the current share repurchase authorization.

As of June 30, 2015, the Company’s cash and cash equivalents totaled $82.4 million. Cash in U.S. demand deposit accounts totaled $7.2 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $75.2 million at June 30, 2015.

Consolidated balance sheet debt decreased by $13.4 million for the current year-to-date, from $273.9 million to $260.5 million. Since last year-end, domestic debt decreased by $10.0 million and foreign debt decreased by $3.4 million. Net debt (which is defined as total debt minus cash) decreased by $10.6 million for the current year-to-date, from $188.7 million to $178.1 million. As of June 30, 2015, the ratio of total debt to total debt plus shareholders’ equity was 32.1 percent compared to 33.8 percent at December 31, 2014. As of June 30, 2015, the ratio of net debt to net debt plus shareholders’ equity was 24.4 percent, compared to 26.0 percent at December 31, 2014.

At June 30, 2015, the Company’s debt included $232.1 million of unsecured private placement loans with maturities extending from 2015 through 2025. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

The Company has a committed $125.0 million multi-currency syndicated revolving credit agreement. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through July 10, 2019, with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of June 30, 2015, the Company had borrowings of $10.0 million and outstanding letters of credit of $5.0 million under this agreement, with $110.0 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At June 30, 2015, the Company’s European subsidiaries had bank term loans of $4.4 million with maturities through 2021 and short-term bank debt of $12.6 million with remaining short-term borrowing capacity of $14.3 million. The Company’s Latin American subsidiaries had no short-term bank debt with $12.2 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $1.3 million of short-term bank loans, which were guaranteed by the Company, with $5.7 million of unused borrowing capacity.

On July 10, 2015, the Company completed a new $100.0 million unsecured private placement loan. See Note 18 to the condensed consolidated financial statements for additional information.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Quimica Ltda., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.

2. The Restricted Group must maintain net worth of at least $325.0 million.

3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.

The Restricted Group may pay dividends and purchase treasury shares after December 31, 2013, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2014. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12, Debt, in the Notes to Consolidated Financial Statements.

The Company believes it was in compliance with all of its loan agreements as of June 30, 2015. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2015.

ENVIRONMENTAL AND LEGAL MATTERS

The Company’s operations are subject to extensive federal, state and local environmental laws and regulations. Although the Company's environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first six months of 2015 and 2014, the Company’s expenditures for capital projects related to the environment were $0.8 million and $1.8 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $10.5 million and $9.6 million for the six months ended June 30, 2015 and 2014, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $20.7 million to $41.1 million at June 30, 2015, compared to $21.9 million to $41.8 million at December 31, 2014. At June 30, 2015, and December 31, 2014, the Company's accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $20.7 million and $22.0 million, respectively. During the first six months of 2015 and 2014, cash outlays related to legal and environmental matters approximated $1.9 and $0.5 million, respectively.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

OTHER DEVELOPMENTS

In July 2015, the Company signed a long-term supply agreement with The Sun Products Corporation (SUN) and, separately, also reached an agreement to purchase select chemical manufacturing assets from SUN's Pasadena, Texas manufacturing site. See Note 18 to the condensed consolidated financial statements for additional information.

OUTLOOK

After six months, the Company remains on track to re-establish earnings momentum for the full year. In the second half, Surfactant earnings should benefit from new commodity laundry volumes in North and Latin America, continued diversification of the Company’s business in Europe as well as contributions from improved operations and the Company’s efficiency program. Management expects continued Polymer income growth in 2015 driven by higher polyol volumes used in rigid insulation and metal panels. The construction projects to add polyol capacity in China and Poland are progressing, and both should start production in 2016.

CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2014 Annual Report on Form 10-K.

Controls and procedures

As filed, 728 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of June 30, 2015.

b. Changes in Internal Control Over Financial Reporting

There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-04-01 to 2015-06-30$452.4mus-gaap:SalesRevenueNet
Revenue6 months2015-01-01 to 2015-06-30$912.9mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-04-01 to 2015-06-30$372.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2015-01-01 to 2015-06-30$756.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2015-04-01 to 2015-06-30$79.5mus-gaap:GrossProfit
Gross profit6 months2015-01-01 to 2015-06-30$156.0mus-gaap:GrossProfit
Operating income3 months2015-04-01 to 2015-06-30$28.6mus-gaap:OperatingIncomeLoss
Operating income6 months2015-01-01 to 2015-06-30$63.8mus-gaap:OperatingIncomeLoss
Income tax3 months2015-04-01 to 2015-06-30$7.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2015-01-01 to 2015-06-30$16.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-04-01 to 2015-06-30$16.9mus-gaap:NetIncomeLoss
Net income6 months2015-01-01 to 2015-06-30$38.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-04-01 to 2015-06-30$0.74us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2015-01-01 to 2015-06-30$1.67us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-04-01 to 2015-06-30$0.74us-gaap:EarningsPerShareBasic
Basic EPS6 months2015-01-01 to 2015-06-30$1.68us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-04-01 to 2015-06-3022,871,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2015-01-01 to 2015-06-3022,850,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2015-01-01 to 2015-06-30$78.3mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2015-01-01 to 2015-06-30$54.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2015-01-01 to 2015-06-30$8.1mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2015-06-30$82.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-06-30$564.4mus-gaap:AssetsCurrent
Total assetsAt period end2015-06-30$1.16bnus-gaap:Assets
Current liabilitiesAt period end2015-06-30$234.0mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2015-06-30$235.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2015-06-30$24.8mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2015-06-30$550.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-15-005756. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.